1417917-74-8

Basic information

• Product Name: 2-(3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)acetonitrile
• Synonyms: 2-(3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)acetonitrile
• CAS NO: 1417917-74-8
• Molecular Weight: 341.41
• Mol File: 1417917-74-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)acetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)acetonitrile(1417917-74-8)
• EPA Substance Registry System: 2-(3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)acetonitrile(1417917-74-8)

Safety Data

• Hazardous Substances Data: 1417917-74-8(Hazardous Substances Data)

Upstream product

• 1417917-67-9 3-[4-(4-methoxybenzoyl)piperidin-1-yl]pyrrolidin-2-one 
• 107-14-2 chloroacetonitrile 
• 25519-82-8 (4-methoxy-phenyl)-piperidin-4-yl-methanone hydrochloride 
• 178946-17-3 (R,S)-2,4-Dibromo-N-cyanomethyl-butyramide 
• 76362-12-4 4-(4-methoxybenzoyl)-piperidine 

Downstream Products

• 1417917-75-9 2-(3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)acetimidamide hydrochloride 
• 1417917-78-2 2-{3-[4-(4-methoxybenzoyl)piperidin-1-yl]-2-oxo-pyrrolidin-1-yl}acetamidine 
• 1417917-41-9 2-((3-(4-(4-methoxybenzoyl)piperidin-1-yl)-2-oxopyrrolidin-1-yl)methyl)-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417917-42-0 2-{3-[4-(4-Methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-3H-pyrimidin-4-one 
• 1417917-43-1 2-{3-[4-(4-Methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-6-methyl-3H-pyrimidin-4-one 
• 1417917-44-2 6-Ethyl-2-{3-[4-(4-methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-3H-pyrimidin-4-one 
• 1417917-46-4 2-{3-[4-(4-Methoxy-benzoyl)-piperidin-1-yl]-2-oxo-pyrrolidin-1-ylmethyl}-5,6-dimethyl-3H-pyrimidin-4-one 

Relevant articles and documents

4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

The present invention provides for compounds of formula (I).The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as for the use of such compounds as tankyrase inhibitors and in the treatment of Wnt signaling and tankyrase 1 and 2 signaling related disorders which include, but are not limited to, cancer.